Skip to main content
OpenTrials
Completed

NCT Number: NCT06467487

Electronic Health Record Strategies to Promote Diverse Participation in Research AIM 2

Based on the outcomes of the initial study (NCT05348603), this optimization study will employ the most effective interventions (letters and messages) and distribute these communications to underrepresented minorities to further promote interest in research. Optimized language will be distributed in English, Spanish, Portuguese, Chinese, Arabic, or Haitian Creole, based on preferred language identified in the patient profile in an electronic medical records system.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Patient Participation Behavior Health Behavior Patient Acceptance of Health Care Treatment Adherence and Compliance

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Yale University

New Haven, Connecticut, 06511, United States

About this study

The primary objective of the optimization study is to examine the effectiveness on increasing interest in research of an optimized letter versus a generic letter; an optimized message versus a generic message; and an optimized letter and an optimized message versus a generic letter and a generic message.

The secondary objective of the optimization study is to examine the effectiveness on increasing participation in research of an optimized letter versus a generic letter, an optimized message versus a generic message, an optimized letter and an optimized message versus a generic letter and a generic message.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Has an account with the online patient portal
  • Has logged into the online patient portal at least once in the past year
  • Has not set up a research profile

Exclusion criteria

  • Currently enrolled in a clinical trial
  • Opted out of research
  • On active cancer treatment
  • Active member of the study team

Treatment and study plan

Traditional Letter

Other

Patients receive a traditional letter.

Direct to Patient Message

Other

Patients receive a direct to patient message via the portal.

Optimized Letter

Other

Patients receive an optimized letter.

Direct to Patient Message - Optimized

Other

Patients receive an optimized direct to patient message via the portal.

Primary outcomes

  1. Number of patients who create a research profile

    Time frame: 12 months

    The outcome will be assessed by querying the patient's electronic medical record to determine whether the patient has registered in the Yale University Volunteer Database. This database is comprised of patients who agree to be contacted if there is a study at Yale that meets their interests.

Secondary outcomes

  1. Number of patients who enroll in a research study

    Time frame: 12 months

    The outcome will be assessed by querying our clinical trials management system or electronic health record system to determine if the patient has consented to participate in a research study.

Sponsors and collaborators

Lead sponsor

Yale University

Other

Collaborators

  • Food and Drug Administration (FDA)

Registry information

Official study title

Leveraging Community Engagement and Electronic Health Record Strategies to Promote Diverse Participation in COVID-19 Clinical Trials -2

Important dates

Study start
2024
Primary completion
2025
Study completion
2025
First posted
Jun 21, 2024
Registry last updated
Jan 13, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.